NVO
As of 2026-05-29, Novo Nordisk A/S (NVO) has a market capitalization of $202.94 B, making it the #67 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-05-29 | $202.94 B |
| 2026-05-28 | $200.19 B |
| 2026-05-26 | $198.94 B |
| 2026-05-25 | $198.94 B |
| 2026-05-24 | $198.94 B |
| 2026-05-22 | $198.94 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-05-29, Novo Nordisk A/S (NVO) has a market capitalization of $202.94 B, making it the #67 most valuable US-listed company.
Novo Nordisk A/S is the #67 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.